Cross Country Healthcare (NASDAQ:CCRN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, Zacks.com reports. The firm currently has a $11.00 price objective on the business services provider’s stock. Zacks Investment Research‘s price target points to a potential upside of 12.36% from the stock’s current price.

According to Zacks, “Cross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. “

A number of other equities research analysts have also recently issued reports on CCRN. ValuEngine cut shares of Cross Country Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. BidaskClub cut shares of Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $9.67.

Shares of NASDAQ:CCRN traded down $0.10 on Tuesday, hitting $9.79. The company had a trading volume of 370,700 shares, compared to its average volume of 164,033. Cross Country Healthcare has a 1-year low of $6.75 and a 1-year high of $12.99. The stock has a market cap of $375.96 million, a price-to-earnings ratio of 81.58, a P/E/G ratio of 4.11 and a beta of 1.30. The stock has a 50 day moving average price of $11.46 and a 200 day moving average price of $10.54. The company has a current ratio of 2.03, a quick ratio of 2.03 and a debt-to-equity ratio of 0.55.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Tuesday, November 5th. The business services provider reported $0.05 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.04. The company had revenue of $209.20 million during the quarter, compared to analysts’ expectations of $202.60 million. Cross Country Healthcare had a negative net margin of 9.44% and a positive return on equity of 1.30%. Cross Country Healthcare’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.02 earnings per share. Sell-side analysts anticipate that Cross Country Healthcare will post 0.14 earnings per share for the current fiscal year.

In related news, CAO Christopher R. Pizzi sold 8,379 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $12.45, for a total transaction of $104,318.55. Following the completion of the sale, the chief accounting officer now owns 42,131 shares of the company’s stock, valued at $524,530.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director W Larry Cash acquired 5,000 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The shares were purchased at an average cost of $12.39 per share, with a total value of $61,950.00. Following the transaction, the director now directly owns 139,306 shares of the company’s stock, valued at $1,726,001.34. The disclosure for this purchase can be found here. Insiders own 3.80% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Atria Investments LLC bought a new stake in Cross Country Healthcare during the second quarter worth about $405,000. Susquehanna International Group LLP bought a new stake in Cross Country Healthcare during the second quarter worth about $119,000. State of Alaska Department of Revenue lifted its position in Cross Country Healthcare by 126.4% during the third quarter. State of Alaska Department of Revenue now owns 28,339 shares of the business services provider’s stock worth $291,000 after purchasing an additional 15,824 shares during the period. State of Tennessee Treasury Department lifted its position in Cross Country Healthcare by 97.7% during the third quarter. State of Tennessee Treasury Department now owns 29,378 shares of the business services provider’s stock worth $303,000 after purchasing an additional 14,520 shares during the period. Finally, Public Employees Retirement System of Ohio bought a new stake in Cross Country Healthcare during the second quarter worth about $276,000. 94.97% of the stock is owned by institutional investors and hedge funds.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Recommended Story: S&P 500 Index

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.